Skip to main content

Month: March 2021

Notice to convene the annual general meeting in FirstFarms A/S

Notice to convene the annual general meeting in FirstFarms A/S The Board of Directors hereby convenes to annual general meeting in FirstFarms A/S, CVR 28 31 25 04.The annual general meeting will be held on Tuesday 27 April 2021 at 2 p.m. in: SAGRO, Majsmarken 1, DK-7190 Billund As it is not possible to hold a normal physical general meeting due to COVID-19, the company will transmit the general meeting via webcast through the company’s shareholder portal. At the latest the day before the annual general meeting, information will be submitted on the shareholder portal on how to access the webcast. If the situation with COVID-19 changes before the end of April 2021, based on recommendations and rules from the government regarding assemblies, we will inform you again. Chairman of the Board of Directors Henrik Hougaard, CEO Anders H....

Continue reading

Indkaldelse til ordinær generalforsamling i FirstFarms A/S

Indkaldelse til ordinær generalforsamling i FirstFarms A/S Bestyrelsen indkalder hermed til ordinær generalforsamling i FirstFarms A/S, CVR 28 31 25 04.Generalforsamlingen afholdes tirsdag den 27. april 2021 kl. 14.00 på: SAGRO, Majsmarken 1, DK-7190 Billund Da det ikke er muligt med afholdelse af en normal fysisk generalforsamling grundet COVID-19, vil selskabet transmittere generalforsamlingen via webcast gennem selskabets aktionærportal. Der vil på aktionærportalen, senest dagen før generalforsamlingen ligeledes komme informationer omkring hvordan man tilgår webcast. Ændrer situationen sig omkring COVID-19 inden udgangen af april 2021 ud fra regeringens anbefalinger eller regler vedrørende forsamlinger, vil vi orientere yderligere. Bestyrelsesformand Henrik Hougaard, adm. direktør Anders H. Nørgaard samt dirigent Jon Stefansson vil...

Continue reading

China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)

China NMPA approval follows 2020 U.S. FDA approval for the treatment of patients with fourth-line GIST QINLOCK demonstrated a significant improvement in progression-free survival and a clinically meaningful benefit in overall survival compared to placebo in the pivotal Phase 3 INVICTUS study QINLOCK approval is the third innovative oncology product approval Zai Lab received in the last 15 months SHANGHAI, SAN FRANCISCO and WALTHAM, Mass., March 31, 2021 (GLOBE NEWSWIRE) — Zai Lab (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, and Deciphera Pharmaceuticals (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced that the China National Medical Products Administration (NMPA) has approved its New Drug...

Continue reading

Greenlane Reports Record Core Business Revenue of $125.2 Million in 2020

BOCA RATON, Fla., March 31, 2021 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of the largest global sellers of premium cannabis accessories and specialty vaporization products, today reported financial results for the fourth quarter and year ended December 31, 2020. Note, for the highlights below, core revenue is defined as all non-nicotine revenue and Greenlane Brand revenue is inclusive of Eyce figures. Full Year 2020 (“FY 2020”) HighlightsTotal revenue for FY 2020 was $138.3 million compared to $185.0 million for FY 2019; Full year 2020 Core revenue (defined as non-nicotine revenue) grew 12.7% to $125.2 million, compared to $111.1 million in FY 2019; Merchandise Gross Margin (defined as sale price less the cost of merchandise) increased to 28.2% compared for FY 2020 compared...

Continue reading

Kirkland Lake Gold Announces Filing of Detour Lake Technical Report, Including New Life-Of-Mine Plan

Highlights of the 2021 Life-of-Mine Plan (“LOMP”):Production of 680,000 – 720,000 ounces from 2021 – 2024, growing to 800,000 ounces in 2025 and reaching over 900,000 ounces in 2032 Low unit costs, including average operating cash costs of $524/oz and AISC/oz of $775 in first five years (2021 – 2025) Large Mineral Reserve provides 22-year production life with potential for further growth Encouraging exploration results supporting substantial growth in Mineral Reserves, higher production levels and further improvements to unit costs not included in 2021 LOMP (to be superseded by new mine plan in 2022).TORONTO, March 31, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced the filing of a technical report (the “ 2021 Detour Lake Technical Report” or...

Continue reading

Orange Belgium invites investors and analysts to participate to its Q1 results conference call on April 21, 2021

Orange Belgium will publish its results for the first quarter of 2021 on Wednesday, April 21 at 07:00 CET. Orange Belgium Investor Relations is pleased to invite investors and analysts to participate in a conference call hosted by:Xavier Pichon, CEO Antoine Chouc, CFO Koen Van Mol, Investor RelationsThe conference call will start at 2:00 pm CET (1:00 pm UK / 8:00 am EST). To access the call, please dial one of the following numbers 5-10 minutes prior to the start of the conference call in order to avoid waiting time. Consequently register with following pin code: 48339699# and provide your name and the company you work for.Belgium +32 24035816Canada +1 4162164194France +33 172727403Germany +49 69222225429Ireland +353 15060451Italy +39 0236013817Luxembourg +352 27300163Netherlands +31 207095119Spain +34 911140101Switzerland +41...

Continue reading

Orange Belgium nodigt investeerders en analisten uit om deel te nemen aan een conference call op 21 april n.a.v. de resultaten van het eerste kwartaal 2021

Orange Belgium zal zijn resultaten voor het eerste kwartaal 2021 op woensdag 21 april om 7:00 lokale tijd publiceren. Het Investor Relations team van Orange Belgium is verheugd investeerders en analisten uit te nodigen voor een conference call naar aanleiding van de financiële resultaten. De conferentie zal worden voorgezeten door:Xavier Pichon, CEO Antoine Chouc, CFO Koen Van Mol, Investor RelationsDe conferentie start om 14:00 lokale tijd (13:00 UK / 04:00 EST). Om toegang te krijgen tot de conferentie, gelieve in te bellen op één van de volgende nummers. Mogen we U vragen om 5-10 minuten voorafgaand aan de start van de conferentie in te bellen om eventuele onvoorziene wachttijden te voorkomen? Vervolgens kan U registreren met volgende pincode: 48339699# en het verstrekken van uw naam en het bedrijf waar U werkt. België +32 24035816Canada +1...

Continue reading

Orange Belgium invite les investisseurs et les analystes à prendre part à la conférence téléphonique organisée le 21 avril 2021 dans le cadre de ses résultats du premier trimestre 2021

Orange Belgium communiquera ses résultats pour le premier trimestre 2021 le mercredi 21 avril à 07h00 CET. L’équipe Relations Investisseurs d’Orange Belgium a le plaisir d’inviter les investisseurs et les analystes à prendre part à la conférence téléphonique donnée par:Xavier Pichon, CEO Antoine Chouc, CFO Koen Van Mol, Investor Relations  La conférence téléphonique débutera à 14h00 CET (13h00 UK / 8h00 EST). Pour y prendre part, veuillez former un des numéros repris dans le tableau ci-dessous 5-10 minutes avant le début de la conférence afin d’éviter tout temps d’attente. Il vous faudra ensuite donner le code pin: 48339699# ainsi que votre nom et la société pour laquelle vous travaillez.Belgique +32 24035816Canada +1 4162164194France +33 1172727403Allemagne +49 69222225429Irlande +353 15060451Italie +39 0236013817Luxembourg +352...

Continue reading

Meddelelse nr. 05/2021: Indkaldelse til ordinær generalforsamling

I henhold til vedtægterne indkaldes herved til ordinær generalforsamling fredag d. 23. april 2021 kl. 17.00 hos Mazanti-Andersen Korsø Jensen Advokatpartnerselskab, Amaliegade 10, DK-1256 København K. I overensstemmelse med myndighedernes generelle anbefalinger for begrænsning af spredningen af Covid-19, herunder det gældende forsamlingsforbud, henstiller bestyrelsen til at aktionærer afstår fra at deltage fysisk i generalforsamlingen, men i stedet benytter sig af muligheden for at afgive brevstemme eller fuldmagt. Brevstemme, bestyrelsesfuldmagt og afkrydsningsfuldmagt kan afgives skriftligt og elektronisk via aktionærportalen på selskabets hjemmeside. Proceduren er nærmere beskrevet sidst i indkaldelsen. Det vil være muligt at følge generalforsamlingen virtuelt. Link til general­forsamlingen vil blive offentligjort på selskabets hjemmeside....

Continue reading

Børsmeddelelse nr. 06.2021 Indkaldelse til ordinær generalforsamling

Hermed indkaldes til ordinær generalforsamling i SmallCap Danmark A/S (CVR nr. 39703416) fredag d. 23. april 2021 kl. 16.00 hos Mazanti-Andersen Korsø Jensen Advokatpartnerselskab, Amaliegade 10, DK-1256 København K. I overensstemmelse med myndighedernes generelle anbefalinger for begrænsning af spredningen af Covid-19, herunder det gældende forsamlingsforbud, henstiller bestyrelsen til at aktionærer afstår fra at deltage fysisk i generalforsamlingen, men i stedet benytter sig af muligheden for at afgive brevstemme eller fuldmagt. Brevstemme, bestyrelsesfuldmagt og afkrydsningsfuldmagt kan afgives skriftligt og elektronisk via aktionærportalen på selskabets hjemmeside. Proceduren er nærmere beskrevet sidst i indkaldelsen. Det vil være muligt at følge generalforsamlingen virtuelt. Link til general­forsamlingen vil blive offentligjort på...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.